PINOTBIO, INC. – Trademark Portfolio

Entity Type: 03

PINOTBIO, INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PINOTBIO and PINOT THERAPEUTICS. The owner is based in Suwon-si, Gyeonggi-do.

Rooms 803-808, 813, Gwanggyo Business

Center, 156, Gwanggyo-ro, Yeongtong-gu

Suwon-si, Gyeonggi-do 16506 , KR

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PINOTBIO, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does PINOTBIO, INC. have?

PINOTBIO, INC. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does PINOTBIO, INC. file in?

PINOTBIO, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are PINOTBIO, INC.'s most well-known trademarks?

PINOTBIO, INC.'s registered trademark portfolio includes well-known marks such as PINOTBIO and PINOT THERAPEUTICS. These are among 2 currently registered trademarks in the portfolio.

What is PINOTBIO, INC.'s trademark registration success rate?

PINOTBIO, INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.